Results 91 to 100 of about 37,864 (312)

Virtual birefringence imaging and histological staining of amyloid deposits in label-free tissue using autofluorescence microscopy and deep learning [PDF]

Nature Communications (2024)
Systemic amyloidosis is a group of diseases characterized by the deposition of misfolded proteins in various organs and tissues, leading to progressive organ dysfunction and failure. Congo red stain is the gold standard chemical stain for the visualization of amyloid deposits in tissue sections, as it forms complexes with the misfolded proteins and ...
arxiv   +1 more source

Cardiac Amyloidosis Treatment

Methodist DeBakey Cardiovascular Journal, 2022
Cardiac amyloidosis (CA) is a restrictive cardiomyopathy with a traditionally poor prognosis. Until recently, CA treatment options were limited and consisted predominantly of managing symptoms and disease-related complications. However, the last decade has seen significant advances in disease-modifying therapies, increased awareness of CA, and improved
Lily K. Stern, Jignesh Patel
openaire   +2 more sources

Cardiac magnetic resonance left atrioventricular coupling index as a prognostic tool in hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims A novel marker left atrioventricular coupling index (LACI) has been proved to be associated with cardiovascular events in patients without history of cardiovascular disease. However, the studies on cardiac magnetic resonance‐derived LACI in hypertrophic cardiomyopathy (HCM) patients are limited, and the prognostic value of LACI has still ...
Jinyang Wen, Junhao Tu, Xinwei Tao, Yuanyuan Tang, Zhaoxia Yang, Ziyi Pan, Yi Luo, Chunlin Xiang, Dazhong Tang, Lu Huang, Liming Xia   +10 more
wiley   +1 more source

Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis

JACC. CardioOncology, 2020
Objectives: This study determined the diagnostic and prognostic usefulness of hepatocyte growth factor (HGF) in light chain and transthyretin cardiac amyloidosis.
Kathleen W. Zhang, MD, Jennifer Miao, MD, Joshua D. Mitchell, MD, Jose Alvarez-Cardona, MD, Kelsey Tomasek, BS, Yan Ru Su, MD, Mary Gordon, RN, R. Frank Cornell, MD, Daniel J. Lenihan, MD   +8 more
doaj  

Detection and Diagnosis of Cardiac Amyloidosis in Egypt

Cardiology and Therapy, 2023
Plain Language Summary Diagnostic algorithms are useful tools for guiding clinical diagnosis by summarizing diagnostic approaches and defining the patient pathway.
Mohamed Abdelghany, Magdy Abdelhamid, Adel Allam, Adel El Etriby, Sherif Hafez, Hany Ragy, Mohamed Sobhy   +6 more
doaj   +1 more source

Unique type of isolated cardiac valvular amyloidosis [PDF]

, 2006
BACKGROUND: Amyloid deposition in heart is a common occurrence in systemic amyloidosis. But localised valvular amyloid deposits are very uncommon. It was only in 1922 that the cases of valvular amyloidosis were reported.
David Lawrence, E Falk, G Kann, JH Cooper, PH Groves, Salma Reehana, Shehzad Iqbal, Y Goffin   +7 more
core   +3 more sources

Direct Multitype Cardiac Indices Estimation via Joint Representation and Regression Learning [PDF]

, 2017
Cardiac indices estimation is of great importance during identification and diagnosis of cardiac disease in clinical routine. However, estimation of multitype cardiac indices with consistently reliable and high accuracy is still a great challenge due to the high variability of cardiac structures and complexity of temporal dynamics in cardiac MR ...
arxiv   +1 more source

Prediction of 90 day mortality in elderly patients with acute HF from e‐health records using artificial intelligence

ESC Heart Failure, EarlyView.
Abstract Aims Mortality risk after hospitalization for heart failure (HF) is high, especially in the first 90 days. This study aimed to construct a model automatically predicting 90 day post‐discharge mortality using electronic health record (EHR) data 48 h after admission and artificial intelligence. Methods All HF‐related admissions from 2015 to 2020
Joconde Weller, Johann Gutton, Guillaume Hocquet, Leïla Pellet, Marie‐José Aroulanda, Amélie Bruandet, Didier Theis, Fabio Boudis, Romain Cador, Pierre Zweigenbaum, Anne Buronfosse, Pascal de Groote, Michel Komajda   +12 more
wiley   +1 more source

H2FPEF and HFA‐PEFF scores for heart failure risk stratification in hypertrophic cardiomyopathy patients

ESC Heart Failure, EarlyView.
Abstract Aims H2FPEF and HFA‐PEFF scores have demonstrated prognostic value in heart failure (HF) with preserved ejection fraction. This study aimed to explore the value of the H2FPEF and HFA‐PEFF scores for HF risk stratification in patients with hypertrophic cardiomyopathy (HCM).
Yi‐Peng Gao, Hong‐Yun Liu, Xiao‐Jun Bi, Jie Sun, Ying Zhu, Wei Zhou, Ya‐Ting Fan, Xue‐Qing Cheng, Pei‐Na Huang, Ya‐Ni Liu, You‐Bin Deng   +10 more
wiley   +1 more source

Imaging cardiac innervation in amyloidosis [PDF]

, 2019
Cardiac amyloidosis is a form of restrictive cardiomyopathy resulting in heart failure and potential risk on arrhythmia, due to amyloid infiltration of the nerve conduction system and the myocardial tissue.
Glaudemans, Andor W J M, Hazenberg, Bouke P C, Noordzij, Walter, Slart, Riemer H J A   +3 more
core   +6 more sources